Genetically Modified Candida for Hydroxy Fatty Acid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing α,ω-hydroxyacids and diacids are limited by harsh chemical reagents, lack of selectivity, and inefficiencies in ricinoleic acid production, which also pose safety concerns due to allergenic compounds and toxic byproducts, while there is a need for a broader range of agro-based hydroxyl fatty acids for various industrial applications.
Innovation Solution
Genetically modified strains of the yeast Candida are used to biocatalytically convert fatty acids into ω-hydroxy fatty acids and α,ω-dicarboxylic acids with additional functional groups, allowing for the production of ricinoleic acid analogs that can be used as monomers for polymer synthesis, offering higher reactivity and broader applicability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If castor oil is used as the primary source of ricinoleic acid, then hydroxyl functional groups are provided for chemical derivatization, but allergenic compounds and toxic byproducts harm workers and create safety concerns
Solution Approach 1:
The patent extracts and eliminates the harmful components (allergenic compounds and toxic byproducts) from the castor oil production system by using genetically modified Candida strains that selectively produce hydroxyl functional groups without the associated harmful substances, thereby separating the useful function from the harmful effects
Solution Approach 2:
The patent introduces genetically modified Candida yeast strains as intermediary biocatalysts that mediate the conversion of fatty acids to hydroxyl functional groups, replacing the direct chemical processing of castor oil and thereby eliminating exposure to harmful compounds while maintaining the desired chemical functionality
2Productivity
If chemical routes are used to produce ricinoleic acid analogs, then production capacity is achieved, but multiple steps and harsh chemical reagents are required with poor selectivity
Solution Approach 1:
The patent replaces complex chemical synthesis systems with a biological system (genetically modified Candida strains) that performs the same function through enzymatic catalysis, eliminating the need for multiple chemical steps and harsh reagents while maintaining production capacity
Solution Approach 2:
The patent changes the fundamental parameters of the production system from chemical to biological, using living cells with engineered metabolic pathways to perform the synthesis, thereby achieving high selectivity and simplified process conditions while maintaining productivity
3Quantity of substance
If ricinoleic acid is produced from castor oil, then high-volume products are obtained, but the spectrum of agro-based hydroxyl fatty acids is limited
Solution Approach 1:
The patent creates a universal biocatalytic platform using genetically modified Candida strains that can process various fatty acid substrates to produce different hydroxyl fatty acid products, thereby achieving both high-volume production and broad product spectrum from a single system
Solution Approach 2:
The patent introduces dynamic flexibility to the production system by enabling the same biological platform to be adjusted and reconfigured to produce different hydroxyl fatty acid analogs based on the substrate fed to the cells, allowing adaptation to various product requirements while maintaining high-volume production capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of ricinoleic acid analogs with high yield and selectivity, suitable for a wide range of industrial applications, including biodegradable polymers and medical materials, under mild reaction conditions without the need for harsh chemicals.
Implementation Method 1
Genetically modified strains of the yeast Candida are used to biocatalytically convert fatty acids into ω-hydroxy fatty acids and α,ω-dicarboxylic acids
Implementation Method 2
producing an α-carboxyl-ω-hydroxy fatty acid by fermenting the genetically modified Candida host cell
Data Source
AI summary
A substantially pure Candida host cell for the production of a α-carboxyl-ω-hydroxy fatty acid having a carbon chain length in the range from C6 to C22, a α,ω-dicarboxylic fatty acid having a carbon chain length in the range from C6 to C22, or mixtures thereof, is provided. The Candida host cell is characterized by a first genetic modification class and a second genetic modification class. The first genetic modification class comprises one or more genetic modifications that disrupt the peroxisomal β-oxidation pathway. The second genetic modification class comprises one or more genetic modifications that collectively or individually disrupt at least one gene selected from the group consisting of a CYP52A type cytochrome P450, a fatty alcohol oxidase, and an alcohol dehydrogenase.